EUVIMEDEUVIMED entdecken
Open Access

Acute Inhibition of Intestinal Neprilysin Enhances Insulin Secretion via GLP-1 Receptor Signaling in Male Mice

Nathalie Esser iD, Thomas O Mundinger, Breanne M Barrow iD, Sakeneh Zraika iD

Endocrinology · 2023

DOI: 10.1210/endocr/bqad055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, 2023. Verfasst von Nathalie Esser und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor, Insulin Secretion, Neprilysin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health, Dick and Julia McAbee Endowed Postdoctoral Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The peptidase neprilysin modulates glucose homeostasis by cleaving and inactivating insulinotropic peptides, including some produced in the intestine such as glucagon-like peptide-1 (GLP-1). Under diabetic conditions, systemic or islet-selective inhibition of neprilysin enhances beta-cell function through GLP-1 receptor (GLP-1R) signaling. While neprilysin is expressed in intestine, its local contribution to modulation of beta-cell function remains unknown. We sought to determine whether acute selective pharmacological inhibition of intestinal neprilysin enhanced glucose-stimulated insulin secretion under physiological conditions, and whether this effect was mediated through GLP-1R. Lean chow-fed Glp1r+/+ and Glp1r−/− mice received a single oral low dose of the neprilysin inhibitor thiorphan or vehicle. To confirm selective intestinal neprilysin inhibition, neprilysin activity in plasma and intestine (ileum and colon) was assessed 40 minutes after thiorphan or vehicle administration. In a separate cohort of mice, an oral glucose tolerance test was performed 30 minutes after thiorphan or vehicle administration to assess glucose-stimulated insulin secretion. Systemic active GLP-1 levels were measured in plasma collected 10 minutes after glucose administration. In both Glp1r+/+ and Glp1r−/− mice, thiorphan inhibited neprilysin activity in ileum and colon without altering plasma neprilysin activity or active GLP-1 levels. Further, thiorphan significantly increased insulin secretion in Glp1r+/+ mice, whereas it did not change insulin secretion in Glp1r−/− mice. In conclusion, under physiological conditions, acute pharmacological inhibition of intestinal neprilysin increases glucose-stimulated insulin secretion in a GLP-1R–dependent manner. Since intestinal neprilysin modulates beta-cell function, strategies to inhibit its activity specifically in the intestine may improve beta-cell dysfunction in type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 ReceptorInsulin SecretionNeprilysinAnimalsMaleMiceDiabetes Mellitus, Type 2Glucagon-Like Peptide 1GlucoseInsulinIntestinesMice, Inbred C57BLThiorphan

Stichwörter der Autor:innen

GLP-1insulin secretionmouseneprilysinthiorphan

Substanzen

Glucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorGlucoseInsulinNeprilysinThiorphan

Autor:innen und Institutionen

  • Department of Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA.
  • Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA 98195, USA.
  • Laboratory of Immunometabolism and Nutrition, GIGA-I3, CHU Liège, University of Liège, Liège, Belgium.

ORCID-Profile: Nathalie Esser, Breanne M Barrow, Sakeneh Zraika

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health
  • Dick and Julia McAbee Endowed Postdoctoral Fellowship
  • French Society of Diabetes
  • Belgian American Educational Foundation
  • Baillet-Latour Found
  • Belgian Association of Diabetes
  • Horlait-Dapsens Foundation

Zitieren

APA

Esser, N., Mundinger, T. O., Barrow, B. M., & Zraika, S. (2023). Acute Inhibition of Intestinal Neprilysin Enhances Insulin Secretion via GLP-1 Receptor Signaling in Male Mice. Endocrinology. https://doi.org/10.1210/endocr/bqad055

Vancouver

Esser N, Mundinger TO, Barrow BM, Zraika S. Acute Inhibition of Intestinal Neprilysin Enhances Insulin Secretion via GLP-1 Receptor Signaling in Male Mice. Endocrinology. 2023. doi:10.1210/endocr/bqad055

BibTeX
@article{Esser2023,
  author = {Esser, Nathalie and Mundinger, Thomas O and Barrow, Breanne M and Zraika, Sakeneh},
  title = {Acute Inhibition of Intestinal Neprilysin Enhances Insulin Secretion via GLP-1 Receptor Signaling in Male Mice},
  journal = {Endocrinology},
  year = {2023},
  doi = {10.1210/endocr/bqad055}
}
Kostenlos starten →